Grail's Galleri multi-cancer early detection blood test receives approval in New York
MLex Summary: Grail's multi-cancer early detection blood test Galleri has received approval from the New York State Department of Health, the company said. The test is now commercially available to patients...To view the full article, register now.
Already a subscriber? Click here to view full article